Invest now
Beryl Drugs share price
Extreme risk
You have to be logged in to add this to Watchlist.- ₹25.00(1.67%)September 7, 2026 15:18:39 PM IST
- NSE
- BSE
- Vol : 2.70 K (NSE + BSE)Last 20 day avg : 2.33 K
Beryl Drugs is trading 1.67% upper at Rs 25.00 as compared to its last closing price. Beryl Drugs has been trading in the price range of 25.19 & 22.60. Beryl Drugs has given 5.09% in this year & 7.29% in the last 5 days. Beryl Drugs has TTM P/E ratio 17.80 as compared to the sector P/E of 37.01.The company posted a net profit of 0.22 Crores in its last quarter.Listed peers of Beryl Drugs include Sun Pharmaceutical Industries (0.04%), Divi's Laboratories (2.25%), Torrent Pharmaceuticals (1.30%).The Mutual Fund holding in Beryl Drugs was at -% in . The MF holding has - from the last quarter. The FII holding in Beryl Drugs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 07 Sep 2026, 08:15 PM IST
- BetaLow volatility0.63Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.25The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-1.08The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Beryl Drugs Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,899.80 | 0.04 | 4,55,814.91 | 39.02 | 5.64 | 0.81 | 0.47 |
| Divi's Laboratories | 9,305.00 | 2.25 | 2,47,018.51 | 84.76 | 13.27 | 0.36 | 0.03 |
| Torrent Pharmaceuticals | 4,913.00 | 1.30 | 1,86,868.05 | 76.81 | 20.29 | 0.76 | 141.16 |
| Cipla | 1,395.95 | 0.79 | 1,12,772.26 | 28.37 | 3.43 | 0.89 | 1.11 |
| Zydus Lifesciences | 1,155.00 | 3.03 | 1,15,211.69 | 20.94 | 4.19 | 0.09 | 14.22 |
Beryl Drugs Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-09-02 | A.G.M. |
| 2026-08-11 | Quarterly Results |
| 2026-06-16 | Others |
| 2026-05-28 | Audited Results |
| 2026-04-01 | Notice of EGM & Others |
About the company Beryl Drugs
- IndustryBiotechnology & Drugs
- ISININE415H01017
- BSE Code524606
- NSE Code
Beryl Drugs Limited is an India-based pharmaceutical manufacturing company which is principally engaged in the manufacturing of bulk drugs. The Company operates in Pharmaceutical Industry segment. In response to product requirements, it provides a variety of manufacturing options, such as small volume injectable in liquid or dry powder form, as well as a selection of eye and ear drops, intravenous (IV) fluids in glass bottles and poly packs, and veterinary medications. It is also involved in domestic, institutional and export supply. The Company uses its nationwide sales and distribution network to market a variety of branded and generic pharmaceutical formulations. Its manufacturing facility is in Pithampur, India.
Beryl Drugs Share Price FAQs
Beryl Drugs is trading at 25.00 as on Mon Sep 07 2026 09:48:39. This is 1.67% upper as compared to its previous closing price of 24.59.
The market capitalization of Beryl Drugs is 12.60 Cr as on Mon Sep 07 2026 09:48:39.
The 52 wk high for Beryl Drugs is 27.60 whereas the 52 wk low is 15.92
Beryl Drugs can be analyzed on the following key metrics -
- TTM P/E: 17.80
- Sector P/E: 37.01
- Dividend Yield: 0.00%
- D/E ratio: -
Beryl Drugs reported a net profit of 0.42 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Beryl Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.